Free shipping on all orders over $ 500

Oprozomib

Cat. No. M2150

All AbMole products are for research use only, cannot be used for human consumption.

Oprozomib Structure
Synonym:

ONX 0912, PR-047

Size Price Availability Quantity
1mg USD 75 In stock
5mg USD 150 In stock
10mg USD 210 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Oprozomib (ONX 0912, PR-047) is an orally bioavailable and selective proteasome inhibitor. Oprozomib (ONX 0912) selectively inhibited CT-L activity of both the constitutive proteasome (beta5) and immunoproteasome (LMP7) and demonstrated an absolute bioavailability of up to 39% in rodents and dogs. Oprozomib inhibits growth and induces apoptosis in MM cells resistant to conventional and bortezomib therapies. The anti-MM activity of Oprozomib (ONX 0912) is associated with activation of caspase-8, caspase-9, caspase-3, and poly(ADP) ribose polymerase, as well as inhibition of migration of MM cells and angiogenesis. Oprozomib significantly reduced tumor progression and prolonged survival in animal tumor model studies. Immununostaining of MM tumors from ONX 0912-treated mice showed growth inhibition, apoptosis, and a decrease in associated angiogenesis. Finally, Oprozomib (ONX 0912) enhances anti-MM activity of bortezomib, lenalidomide dexamethasone, or pan-histone deacetylase inhibitor.

Chemical Information
Molecular Weight 532.61
Formula C25H32N4O7S
CAS Number 935888-69-0
Solubility (25°C) DMSO 100 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Chauhan D, et al. Blood. A novel orally active proteasome inhibitor ONX 0912 triggers in vitro and in vivo cytotoxicity in multiple myeloma.

[2] Zhou HJ, et al. J Med Chem. Design and synthesis of an orally bioavailable and selective peptide epoxyketone proteasome inhibitor (PR-047).

Related Proteasome Products
Bortezomib (PS-341)

Bortezomib (PS-341) is a highly selective proteasome inhibitor with a ki value of 6nM.

CTP-518

CTP-518 is a novel HIV protease inhibitor. CTP-518 has the potential to be the first HIV protease inhibitor toeliminate the need to co-dose with a boosting agent.

ITMN-191

ITMN-191 (Danoprevir, RG7227) is a potent and orally active inhibitor of hepatitis C virus (HCV) NS3/4A serine protease with an IC50 of 1.6 nM.

MG132

MG132 is a specific and potent cell-permeable proteasome inhibitor (IC50 = 100 nM, Ki = 4 nM). MG-132 effectively blocks the proteolytic activity of the 26S proteasome complex. MG-132 is also a calpain inhibitor with IC50 of 1.2 μM.

IU1

IU1 is a reversible, small molecule inhibitor of deubiquitination by USP14 that demonstrates an IC50 value of 4-5 μM.

  Catalog
Abmole Inhibitor Catalog




Keywords: Oprozomib, ONX 0912, PR-047 supplier, Proteasome, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.